top of page
![](https://static.wixstatic.com/media/3ce396_618b277abe764afda3e875ccd05604a9~mv2.png/v1/fill/w_842,h_595,al_c,q_90,enc_auto/3ce396_618b277abe764afda3e875ccd05604a9~mv2.png)
![ASCTN_logo_master-wo-background-real.png](https://static.wixstatic.com/media/3ce396_ea4ef75b316f440fb2650cb94d5dcdd9~mv2.png/v1/crop/x_99,y_160,w_660,h_269/fill/w_148,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/ASCTN_logo_master-wo-background-real.png)
A summary of the ASCTN project
FIND US ON TWITTER
![salaBlanca00_112.jpg](https://static.wixstatic.com/media/3ce396_398e379fcad84865a4f21102446596ea~mv2_d_5472_3648_s_4_2.jpg/v1/fill/w_395,h_263,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/salaBlanca00_112.jpg)
ASCTN PROJECT
ASCTN-Training is a four-year project, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 813851. ASCTN-Training is addressing existing gaps within Human Stem Cell-based Neuronal disorders (NDs) Modelling (NDM) for research to develop new medicines for the treatment of neurological disorders (e.g. Parkinson´s (PD), Huntington´s (HD) and Demyelination's (DM) diseases), which occur as a result of acute or progressive loss of cells, glial or neuronal, and structures and function in the brain.
![](https://static.wixstatic.com/media/ba47e4_3b7dc6650f2b44c9b1aa3385a9991c27~mv2.jpg/v1/fill/w_427,h_320,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/ba47e4_3b7dc6650f2b44c9b1aa3385a9991c27~mv2.jpg)
![](https://static.wixstatic.com/media/ba47e4_2971b99307634769aa1b7ecad8fafc84~mv2.jpg/v1/fill/w_456,h_320,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/ba47e4_2971b99307634769aa1b7ecad8fafc84~mv2.jpg)
WHAT'S NEW ON INSTAGRAM
bottom of page